Nanogen Says Q4 Revenues Will Be Lower than Expected | GenomeWeb

NEW YORK, Jan 9 – Nanogen announced Tuesday it will post lower-than-expected fourth-quarter revenues due to lowered sales of NanoChip custom electronic microarray cartridges, but noted it had shipped 16 NanoChip molecular biology workstations during the quarter and that its losses for the fourth quarter would remain in line with Wall Street’s expectations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.